Albert Seymour's Insider Trades & SAST Disclosures
Albert Seymour's most recent trade in Q32 Bio Inc. was a trade of 632,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 23, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Albert Seymour.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | Albert Seymour | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 632,000 | 632,000 | - | - | Employee Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Albert Seymour | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 105,000 | 105,000 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 6,930 | 14,070 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 6,930 | 146,786 (0%) | 0% | - | Common Stock | |
| Q32 Bio Inc. | Albert Seymour | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 4,290 | 139,856 (0%) | 0% | - | Common Stock | |
| Q32 Bio Inc. | Albert Seymour | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 4,290 | 4,420 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | Director, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 23,000 | 23,000 | - | - | Employee Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Albert Seymour | Director, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,000 | 14,000 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2022 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 128,000 | 128,000 | - | - | Employee Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 21,000 | 21,000 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 4,290 | 8,710 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 4,290 | 133,307 (0%) | 0% | - | Common Stock | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.78 per share. | 01 Jan 2022 | 1,661 | 131,646 (0%) | 0% | 3.8 | 6,279 | Common Stock |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 78,000 | 78,000 | - | - | Employee Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 13,000 | 13,000 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 06 Jan 2021 | 9,897 | 134,120 (0%) | 0% | 12.1 | 119,395 | Common Stock |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.05 per share. | 06 Jan 2021 | 5,103 | 129,017 (0%) | 0% | 12.0 | 61,469 | Common Stock |
| Q32 Bio Inc. | Albert Seymour | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.44 per share. | 05 Jan 2021 | 10,000 | 144,017 (0%) | 0% | 11.4 | 114,422 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges